Board of Directors

Dr. Iannone brings more than two decades of executive leadership and clinical drug development experience to Pliant.

Dr. Iannone currently serves as Executive Vice President, Research and Development and Chief Medical Officer at Jazz Pharmaceuticals, overseeing clinical operations, product development and regulatory affairs. Prior to joining Jazz, Dr. Iannone held the role of Chief Medical Officer and Head of Research and Development at Immunomedics. Prior to Immunomedics, he held roles of increasing responsibility at AstraZeneca, most recently serving as Senior Vice President and Head of Immuno-oncology, Global Medicines Development. While at AstraZeneca, Dr. Iannone oversaw the development of Imfinzi® (durvalumab). Earlier in his career, Dr. Iannone held management roles at Merck, most recently Executive Director and Section Head of Oncology Clinical Development, serving as a development leader for KEYTRUDA® (pembrolizumab).

In addition to Pliant, Dr. Iannone currently serves on the Board of Directors of Autolus Therapeutics. Dr. Iannone received his M.D. from Yale University School of Medicine with Alpha Omega Alpha honors and a Master of Science in Clinical Epidemiology from the University of Pennsylvania School of Medicine. Dr. Iannone completed his training in Pediatrics and subsequently Pediatric Hematology-Oncology at the Johns Hopkins Hospital before joining the faculty of Medicine at the University of Pennsylvania.